Literature DB >> 30506220

Changes in arterial oxygenation after portal decompression in Budd-Chiari syndrome patients with hepatopulmonary syndrome.

Jiaywei Tsauo1, He Zhao1, Xiaowu Zhang1, Huaiyuan Ma2, Mingshan Jiang2, Ningna Weng2, Xiao Li3,4.   

Abstract

OBJECTIVES: To evaluate the changes in arterial oxygenation after portal decompression in Budd-Chiari syndrome (BCS) patients with hepatopulmonary syndrome (HPS).
METHODS: From June 2014 to June 2015, all patients with BCS who underwent balloon angioplasty or transjugular intrahepatic portosystemic shunt (TIPS) creation at our institution were eligible for inclusion in this study. Arterial blood gas analysis was performed with the patient in an upright position and breathing room air at 2-3 days and 1 and 3 months after the procedure.
RESULTS: Eleven patients with HPS and 14 patients without HPS were included in this study. The procedure was technically successful in 24 patients. One patient with HPS had technically unsuccessful TIPS creation. Reobstruction or TIPS dysfunction was not detected in any patient within 3 months after the procedure. For patients with HPS, the alveolar-arterial oxygen gradient (A-aO2) remained comparable to baseline 2-3 days after the procedure (-3.2 ± 11.9 mmHg; p = .412), significantly improved 1 month after the procedure (-11.7 ± 6.4 mmHg; p < .001), and then returned to baseline 3 months after the procedure (-1.3 ± 12.5 mmHg; p = .757). For patients without HPS, the A-aO2 remained comparable to baseline at all three time points after the procedure (+1.4 ± 8.3 mmHg, +3.5 ± 8.1 mmHg, and +1.3 ± 8.2 mmHg; p = .543, p = .137, and p = .565).
CONCLUSIONS: Arterial oxygenation transiently improves after portal decompression in BCS patients with HPS. KEY POINTS: • Intrapulmonary vascular dilation and hepatopulmonary syndrome are common in patients with Budd-Chiari syndrome. • Arterial oxygenation transiently improves after portal decompression in Budd-Chiari syndrome patients with hepatopulmonary syndrome.

Entities:  

Keywords:  Angioplasty, balloon; Hypertension, portal; Liver cirrhosis; Portosystemic shunt, transjugular intrahepatic

Mesh:

Substances:

Year:  2018        PMID: 30506220     DOI: 10.1007/s00330-018-5840-1

Source DB:  PubMed          Journal:  Eur Radiol        ISSN: 0938-7994            Impact factor:   5.315


  21 in total

Review 1.  Budd-Chiari syndrome: a review by an expert panel.

Authors:  Harry L A Janssen; Juan-Carlos Garcia-Pagan; Elwyn Elias; Gilles Mentha; Antoine Hadengue; Dominique-Charles Valla
Journal:  J Hepatol       Date:  2003-03       Impact factor: 25.083

Review 2.  The Budd-Chiari syndrome.

Authors:  K V Narayanan Menon; Vijay Shah; Patrick S Kamath
Journal:  N Engl J Med       Date:  2004-02-05       Impact factor: 91.245

Review 3.  Pulmonary-Hepatic vascular Disorders (PHD).

Authors:  R Rodríguez-Roisin; M J Krowka; Ph Hervé; M B Fallon
Journal:  Eur Respir J       Date:  2004-11       Impact factor: 16.671

4.  Hepatopulmonary syndrome in candidates for liver transplantation.

Authors:  G P Martínez; J A Barberà; J Visa; A Rimola; J C Paré; J Roca; M Navasa; J Rodés; R Rodriguez-Roisin
Journal:  J Hepatol       Date:  2001-05       Impact factor: 25.083

5.  Occurrence of hepatopulmonary syndrome in Budd-Chiari syndrome and the role of venous decompression.

Authors:  Binay K De; Sambit Sen; Pranab K Biswas; Sanjay K Mandal; Debasish Das; Utpalendu Das; Supriya Guru; Kausik Bandyopadhyay
Journal:  Gastroenterology       Date:  2002-04       Impact factor: 22.682

6.  Hepatopulmonary syndrome: prevalence and predictive value of various cut offs for arterial oxygenation and their clinical consequences.

Authors:  P Schenk; V Fuhrmann; C Madl; G Funk; S Lehr; O Kandel; C Müller
Journal:  Gut       Date:  2002-12       Impact factor: 23.059

7.  Late recurrence and rapid evolution of severe hepatopulmonary syndrome after liver transplantation.

Authors:  M J Krowka; G A Wiseman; J L Steers; R H Wiesner
Journal:  Liver Transpl Surg       Date:  1999-09

8.  Prevalence of hepatopulmonary syndrome in cirrhosis and extrahepatic portal venous obstruction.

Authors:  D Gupta; D R Vijaya; R Gupta; R K Dhiman; M Bhargava; J Verma; Y K Chawla
Journal:  Am J Gastroenterol       Date:  2001-12       Impact factor: 10.864

9.  Hepatopulmonary syndrome and portopulmonary hypertension: a report of the multicenter liver transplant database.

Authors:  Michael J Krowka; M Susan Mandell; Michael A E Ramsay; Steve M Kawut; Michael B Fallon; Cosme Manzarbeitia; Manuel Pardo; Paul Marotta; Shinji Uemoto; Markus P Stoffel; Joanne T Benson
Journal:  Liver Transpl       Date:  2004-02       Impact factor: 5.799

10.  Hepatopulmonary syndrome in noncirrhotic portal hypertensive patients.

Authors:  Sabahattin Kaymakoglu; Tevfik Kahraman; Hasan Kudat; Kadir Demir; Yilmaz Cakaloglu; Isik Adalet; Dinc Dincer; Fatih Besisik; Güngör Boztas; Ahmet Bilge Sözen; Zeynel Mungan; Atilla Okten
Journal:  Dig Dis Sci       Date:  2003-03       Impact factor: 3.199

View more
  1 in total

Review 1.  North American Practice-Based Recommendations for Transjugular Intrahepatic Portosystemic Shunts in Portal Hypertension.

Authors:  Justin R Boike; Bartley G Thornburg; Sumeet K Asrani; Michael B Fallon; Brett E Fortune; Manhal J Izzy; Elizabeth C Verna; Juan G Abraldes; Andrew S Allegretti; Jasmohan S Bajaj; Scott W Biggins; Michael D Darcy; Maryjane A Farr; Khashayar Farsad; Guadalupe Garcia-Tsao; Shelley A Hall; Caroline C Jadlowiec; Michael J Krowka; Jeanne Laberge; Edward W Lee; David C Mulligan; Mitra K Nadim; Patrick G Northup; Riad Salem; Joseph J Shatzel; Cathryn J Shaw; Douglas A Simonetto; Jonathan Susman; K Pallav Kolli; Lisa B VanWagner
Journal:  Clin Gastroenterol Hepatol       Date:  2021-07-15       Impact factor: 13.576

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.